| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | -6.24% | +0.62% | -6.85% | -6.85% | — |
| 14d | 1 | +0.00% | -8.37% | -0.43% | -7.93% | -7.93% | — |
| 30d | 1 | +0.00% | -25.79% | +2.04% | -27.83% | -27.83% | — |
| 60d | 1 | +0.00% | -22.82% | +4.65% | -27.48% | -27.48% | — |
| 90d | 1 | +0.00% | -25.00% | -0.67% | -24.33% | -24.33% | — |
| 180d | 1 | +0.00% | -66.68% | +11.09% | -77.77% | -77.77% | — |
| 1y | 1 | +0.00% | -72.77% | -10.21% | -62.56% | -62.56% | — |
| 2y | 1 | +0.00% | -75.00% | +4.69% | -79.69% | -79.69% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ABOS ACUMEN PHARMACEUTICALS, INC. | SALE | 6,400 | $2.23 | $14.3K | 48,150 | Jun 9, 2026 | Jun 10, 2026 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 53,250 | — | — | 53,250 | Jun 3, 2026 | Jun 5, 2026 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 35,500 | — | — | 54,550 | Jun 3, 2026 | Jun 5, 2026 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 19,500 | — | — | 19,500 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,800 | — | — | 19,050 | Jun 4, 2025 | Jun 5, 2025 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 10, 2024 | Jun 10, 2024 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 6, 2023 | Jun 7, 2023 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Jun 15, 2022 | Jun 17, 2022 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASE | 6,250 | $16.00 | $100.0K | 6,250 | Jul 6, 2021 | Jul 8, 2021 ↗ | View → |
| ABOS ACUMEN PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 34,000 | — | — | 34,000 | Jun 30, 2021 | Jul 2, 2021 ↗ | View → |